Betsy Hirsch

Betsy Hirsch is an Associate Professor in the Department of Experimental and Clinical Pharmacology at the University of Minnesota College of Pharmacy. Her contact details include office phone 612-626-4388 and email ebhirsch@umn.edu. She actively collaborates with institutions like Merck and the Cystic Fibrosis Foundation.

• Education: PGY1 Residency at St. Luke's Episcopal Hospital, Infectious Diseases Pharmacotherapy Fellowship at University of Houston College of Pharmacy
• Research Focus: Multidrug-resistant Gram-negative infections, antimicrobial resistance, diagnostics, and optimizing antibiotic use
• Projects: Assessing infectious diseases pharmacist workforce, evaluating vancomycin exposure targets, studying ceftolozane/tazobactam efficacy

Hirsch's research spans pre-clinical to post-marketing phases, emphasizing translation of laboratory findings to clinical practice. Her work contributes to UN Sustainable Development Goals, particularly health-related targets. She engages in collaborations across the U.S. and internationally, focusing on antimicrobial stewardship and patient outcomes.

In recent publications, Hirsch has explored topics such as heteroresistance in Klebsiella pneumoniae, antimicrobial therapy in cystic fibrosis, and workforce development for infectious diseases pharmacists. Her projects often involve investigating novel antibiotic combinations like ceftolozane-tazobactam and ceftazidime/avibactam against MDR pathogens.

She contributes to initiatives supporting underrepresented pharmacy students and participates in media discussions about antibiotic resistance trends. Her work has been referenced in multiple academic platforms, including Scopus and Mendeley, indicating significant scholarly engagement.